EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Bromodomain‐Containing Protein 4 in Ischemia‐Reperfusion Injury: Mechanisms, Preclinical Evidence, and Translational Challenges

Namrata Vadak iD, Lokesh Kumar Bhatt iD

Cell Biology International · 2026-10 · 50 (10)

DOI: 10.1002/cbin.70223 ↗

At a glance

Übersichtsarbeit in Cell Biology International, published online on 2026-10-14. Written by Namrata Vadak and 1 co-authors. Institution: Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, India. Major MEDLINE topics: Reperfusion Injury, Transcription Factors, Cell Cycle Proteins, Nuclear Proteins. 135 references. Funded by: Department of Science and Technology (DST).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Ischemia reperfusion (IR) injury is a major contributor to tissue damage and organ dysfunction following ischemic events and clinical interventions such as thrombolysis, revascularization, and transplantation, yet effective pharmacological strategies to limit this injury remain limited. Bromodomain‐containing protein 4 (BRD4), an epigenetic reader that recognizes acetylated lysine residues to drive super‐enhancer‐associated transcription. Upregulated BRD4 has emerged as a key regulator of the inflammatory, endothelial, and cell death pathways underlying post‐IR injury pathophysiology. Preclinical evidence across cerebral, cardiac, renal, and hepatic IR injury models indicates that BRD4 hyperactivation amplifies NFκB‐dependent inflammatory signaling, while its pharmacological or genetic inhibition confers substantial tissue protection. This review synthesizes current mechanistic understanding of BRD4 in IR injury pathogenesis, evaluates emerging BET/BRD4‐targeted therapeutic strategies, and outlines key translational challenges for advancing epigenetic pharmacology toward clinical application in IR‐associated disorders.

Subjects

MeSH terms (MEDLINE)

Reperfusion InjuryTranscription FactorsCell Cycle ProteinsNuclear ProteinsHumansBromodomain Containing ProteinsAnimalsEpigenesis, GeneticSignal Transduction

Author keywords

BRD4 inhibitorsJQ1bromodomain‐containing protein 4epigeneticischemia reperfusion injury

Substances

Bromodomain Containing ProteinsTranscription FactorsBRD4 protein, humanCell Cycle ProteinsNuclear Proteins

Authors and institutions

  • Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, India.

ORCID profiles: Namrata Vadak, Lokesh Kumar Bhatt

Funding

  • Department of Science and Technology (DST)

Cite

APA

Vadak, N., & Bhatt, L. K. (2026). Bromodomain‐Containing Protein 4 in Ischemia‐Reperfusion Injury: Mechanisms, Preclinical Evidence, and Translational Challenges. Cell Biology International, 50(10). https://doi.org/10.1002/cbin.70223

Vancouver

Vadak N, Bhatt LK. Bromodomain‐Containing Protein 4 in Ischemia‐Reperfusion Injury: Mechanisms, Preclinical Evidence, and Translational Challenges. Cell Biology International. 2026;50(10). doi:10.1002/cbin.70223

BibTeX
@article{Vadak2026,
  author = {Vadak, Namrata and Bhatt, Lokesh Kumar},
  title = {Bromodomain‐Containing Protein 4 in Ischemia‐Reperfusion Injury: Mechanisms, Preclinical Evidence, and Translational Challenges},
  journal = {Cell Biology International},
  year = {2026},
  volume = {50},
  number = {10},
  doi = {10.1002/cbin.70223}
}
Start for free →